Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept

Helicobacter Pylori

Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag^® H. pylori + ClariR assay

doi: 10.1111/hel.12560.

Helicobacter Pylori

Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent

BMC Gastroenterol

Kakiuchi T, Hashiguchi K, Imamura I, Nakayama A, Takamori A, Okuda M, Matsuo M

doi: 10.1186/s12876-020-01549-9

Helicobacter Pylori

Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication

J Antimicrob Chemother.

De Francesco V, Zullo A, Fiorini G, Saracino IM, Pavoni M, Vaira D

doi: 10.1093/jac/dky469.

RECOMMENDED

Helicobacter Pylori

Review: Helicobacter pylori and non-malignant upper gastrointestinal diseases

Helicobacter.

Boltin D, Niv Y, Schütte K, Schulz C

doi: 10.1111/hel.12637.

RECOMMENDED

Helicobacter Pylori

Review: Diagnosis of Helicobacter pylori infection

Helicobacter.

Makristathis A, Hirschl AM, Mégraud F, Bessède E

doi: 10.1111/hel.12641.

Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization

World J Gastroenterol.

Abadi ATB

doi: 10.3748/wjg.v23.i35.6379.

Helicobacter Pylori

Once-daily rabeprazole, levofloxacin, clarithromycin-MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study)

Helicobacter.

Auttajaroon J, Vilaichone RK, Chotivitayatarakorn P, Mahachai V

doi: 10.1111/hel.12615.

Helicobacter Pylori

N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication

Cochrane Database Syst Rev.

Fontes LES, Martimbianco ALC, Zanin C, Riera R

doi: 10.1002/14651858.

Gastrointestinal CancerHelicobacter Pylori

Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study

Gastroenterology.

Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS

doi: 10.1053/j.gastro.2019.10.019.

Related content

Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag® H. pylori + ClariR assay

Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent

Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication

Review: Helicobacter pylori and non-malignant upper gastrointestinal diseases

Review: Diagnosis of Helicobacter pylori infection

Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization

Once-daily rabeprazole, levofloxacin, clarithromycin-MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study)

N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication

Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study

Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag^® H. pylori + ClariR assay